EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Activating protein kinases to treat diseases: Current understanding and future challenges

Peng Jin, Minru Liao, Huidi Liu, Kun Huang, Leilei Fu, Xin Jin

Acta Pharmaceutica Sinica B · 2026-02 · 16 (2) · 746-769

DOI: 10.1016/j.apsb.2025.12.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-02. Verfasst von Peng Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shengjing Hospital of China Medical University, China Medical University, Shenyang 110004, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Science and Technology Support Program, Southwest Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein kinases, as one of the most important human enzymes, are signaling molecules that regulate almost all cell activities, including growth, cell division and metabolism. Dysfunction of these cellular pathways can lead to a variety of human diseases. Accumulating evidence on the down-regulation of key protein kinases in diseases has made a big progress. The down-regulation is related to cancer, heart disease, neurodegenerative diseases and other diseases. Thus, in this review, we defined the classifications of protein kinases and demonstrated the mechanisms of protein kinase activators in the treatment of human diseases, summarized the research progress of protein kinase activators, and further discussed the development progress of protein kinase activators in clinical stage. Accordingly, activation of protein kinases has become a crucial target for drug development. With the in-depth understanding of protein kinase functions and regulation mechanisms, the development of new protein kinase activators may continue to be a rapidly growing field, which will help to develop more accurate and effective targeted therapeutic strategies in the near future.

Schlagwörter

Stichwörter der Autor:innen

ActivatorClinical trialHuman diseaseProtein kinaseSerine/threonine specific protein kinaseSmall-molecule pharmacological agentTherapeutic strategyTyrosine protein kinase

Autor:innen und Institutionen

  • Department of Urology, Shengjing Hospital of China Medical University, China Medical University, Shenyang 110004, China.
  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.
  • Department of Anus and Intestine Surgery, The First Hospital of China Medical University, China Medical University, Shenyang 110001, China.
  • Department of Ultrasound, The First Hospital of China Medical University, China Medical University, Shenyang 110001, China.

Förderung

  • National Natural Science Foundation of China
  • Sichuan Provincial Science and Technology Support Program
  • Southwest Jiaotong University
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Jin, P., Liao, M., Liu, H., Huang, K., Fu, L., & Jin, X. (2026). Activating protein kinases to treat diseases: Current understanding and future challenges. Acta Pharmaceutica Sinica B, 16(2), 746-769. https://doi.org/10.1016/j.apsb.2025.12.004

Vancouver

Jin P, Liao M, Liu H, Huang K, Fu L, Jin X. Activating protein kinases to treat diseases: Current understanding and future challenges. Acta Pharmaceutica Sinica B. 2026;16(2):746-769. doi:10.1016/j.apsb.2025.12.004

BibTeX
@article{Jin2026,
  author = {Jin, Peng and Liao, Minru and Liu, Huidi and Huang, Kun and Fu, Leilei and Jin, Xin},
  title = {Activating protein kinases to treat diseases: Current understanding and future challenges},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {746--769},
  doi = {10.1016/j.apsb.2025.12.004}
}
Kostenlos starten →